Newsroom
-
Mammoth Biosciences Announces Peer-Reviewed Validation Of Its Rapid, CRISPR-Based COVID-19 Diagnostic
WebWireLearn More -
Mammoth Biosciences Raises $45 Million to Build Next-Generation CRISPR Products For Therapeutics and Diagnostics
WebWireLearn More -
Mammoth Biosciences Licenses 2 UC Patents for CRISPR-Based Diagnostic Platform
Genetic Engineering & Biotechnology NewsLearn More -
Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself
ForbesLearn More -
Mammoth Biosciences Secures Exclusive License to Commercialize Novel CRISPR Protein
WebWireLearn More -
Mammoth Biosciences Licenses New CRISPR Enzyme for Disease Detection Applications
GenomeWebLearn More -